Literature DB >> 76455

Pleural effusion from malignancy.

A Leff, P C Hopewell, J Costello.   

Abstract

Pleural effusion from metastatic malignancy can cause major impairment of respiratory function and eventual death. Although cure is not possible, successful palliative treatment allows months to years of productive life, obviating the need for continuous hospitalization and repeated thoracenteses. Successful palliative treatment requires obliteration of the pleural space. Literature survey indicates that a wide variety of medical agents and surgical methods have been used with variable success. Medical methods include instillation of antineoplastic agents, antimicrobial agents, or colloidal radioisotopes into the pleural space; quinacrine and tetracycline are moderately to highly effective agents, but the toxicity of the former is substantial. Bedside talc poudrage with thoracostomy-tube drainage is a safe and highly effective alternative. Pleurectomy is the definitive method of preventing reaccumulation of pleural fluid that results from metastatic malignancy, even when other methods have failed, but thehigh morbidity and mortality of the procedures mandate careful patient selection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 76455     DOI: 10.7326/0003-4819-88-4-532

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  8 in total

Review 1.  Management of malignant pleural effusions.

Authors:  M H Tattersall; M J Boyer
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

2.  The use of pleurodesis for intractable pleural effusion due to congestive heart failure.

Authors:  D Davidoff; Y Naparstek; M Eliakim
Journal:  Postgrad Med J       Date:  1983-05       Impact factor: 2.401

3.  Sarcoidosis: a cause of innominate vein obstruction and massive pleural effusion.

Authors:  S Javaheri; C A Hales
Journal:  Lung       Date:  1980       Impact factor: 2.584

4.  Management of recurrent malignant pleural effusion in the United Kingdom: survey of clinical practice.

Authors:  L G McAlpine; G Hulks; N C Thomson
Journal:  Thorax       Date:  1990-09       Impact factor: 9.139

5.  A case report and description of the pharmacokinetic behavior of intrapleurally instilled etoposide.

Authors:  J M Jones; E A Olman; M J Egorin; J Aisner
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 6.  Intracavitary chemotherapy for malignant disease confined to body cavities.

Authors:  M Markman
Journal:  West J Med       Date:  1985-03

Review 7.  Diagnosis and treatment of malignant pleural effusion.

Authors:  F H Hausheer; J W Yarbro
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

8.  Hemorrhagic Malignant Pleural Effusion: Diagnosis, Survival Rate, and Response to Talc Pleurodesis.

Authors:  Gadi Lending; Yousef Abed El Ghani; Edward Kaykov; Boris Svirsky; Hector Isaac Cohen; Edward Altman
Journal:  Indian J Surg Oncol       Date:  2020-11-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.